Compass Therapeutics, Inc. (CMPX)
1.90
+0.05
(+2.70%)
USD |
NASDAQ |
Sep 18, 16:00
1.875
-0.02
(-1.32%)
After-Hours: 20:00
Compass Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 45.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -- |
| Ardelyx, Inc. | 94.74% |
| ARS Pharmaceuticals, Inc. | 61.83% |
| Upstream Bio, Inc. | 93.53% |
| Sionna Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -43.10% |
| Return on Assets | -38.04% |
| Return on Invested Capital | -40.75% |
| Return on Net Operating Assets | -777.2% |